För närvarande kan tillfälliga driftstörningar drabba fass.se. Problemet felsöks för närvarande.

FASS logotyp
Receptbelagd

Peka på symbolerna och beteckningarna till vänster för en förklaring.

Kontakt

Sök apotek med läkemedlet i lager

Sök lagerstatus

DACOGEN®

Janssen

Pulver till koncentrat till infusionsvätska, lösning 50 mg
(Vitt till nästan vitt frystorkat pulver.)

Antineoplastiska medel, antimetaboliter, pyrimidinanaloger

Aktiv substans:
ATC-kod: L01BC08
Utbytbarhet: Ej utbytbar
Läkemedel från Janssen omfattas av Läkemedelsförsäkringen.
  • Vad är miljöinformation?

Miljöinformation

Miljöpåverkan

Decitabin

Miljörisk: Användning av decitabin har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning: Det kan inte uteslutas att decitabin är persistent, då data saknas.
Bioackumulering: Decitabin har låg potential att bioackumuleras.


Läs mer

Detaljerad miljöinformation

Predicted Environmental Concentration (PEC)


PEC is calculated according to the following formula:


PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A*(100-R)


PEC = 0.000005393 µg/L


Where:


A = total actual API sales in Sweden for the most recent year 0.03936 kg (total sold amount API in the most recent sales data for Sweden (2022) was distributed by IQVIA in 2023)


R = 0


P = number of inhabitants in Sweden = 10 *106


V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Reference I)


D = factor for dilution of wastewater by surface water flow = 10 (ECHA default) (Reference I)


According to the European Medicines Agency guideline on environmental risk assessment of medicinal products (EMA/CHMP/SWP/4447/00), use of Decitabine is unlikely to represent a risk for the environment, because the predicted environmental concentration (PEC) is below the action limit 0.01 μg/L.


Background information:

For decitabine no environmental fate and effect studies are available.

The reason for this is that in Phase I of the ERA, according to EMA guideline on the Environmental Risk Assessment of Medicinal Products for Human Use (CHMP/SWP/4447/00), the calculated PEC was far below 0.01 µg/L and therefore no further Phase II testing was triggered.

Decitabine is a low volume API, with very limited environmental exposure.


Predicted No Effect Concentration (PNEC)


Ecotoxicological studies

Algae:

Not available


Crustacean:

Acute toxicity

Not available


Chronic toxicity

Not available


Fish:

Acute toxicity

No data available

Chronic toxicity


No data available


Other ecotoxicity data:

Not available


Environmental risk classification (PEC/PNEC ratio)


Not available


Degradation

Biotic degradation

Not available


Conclusion for degradation:

The potential for persistence of Decitabine cannot be excluded, due to lack of data.


Abiotic degradation

Hydrolysis: -

Photolysis: -


Bioaccumulation

Partition coefficient octanol/water:

The partition coefficient octanol/water was found by using ChemSpider. [Reference II]


Log D = -2

pH: 7.4

Method: predicted data generated using ACD/Labs


Bioconcentration factor (BCF):

The bioconcentration factor was found by using ChemSpider. [Reference II]


BCF = 1

pH: 7.4

Method: predicted data generated using ACD/Labs


Conclusion for bioaccumulation: Decitabine has low potential for bioaccumulation.


Excretion (metabolism)

-


PBT/vPvB assessment

-


References

  1. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm

  2. ChemSpider, LN01254469, data is provided by WuXi LabNetwork (http://www.chemspider.com/Chemical-Structure.397844.html?rid=02568784-dbf7-43ad-a463-3c9a31763b94